orforglipron vs oral semaglutide HUGE news in the GLP-1 space! has outperformed in the ACHIEVE-3 clinical trial in patients with type 2 diabetes. Comment your thoughts below! ⬇️ Orforglipron vs Semaglutide vs Tirzepatide

Summary Keywords glucagon like peptide-1, irritable bowel syndrome, pain, IBS, agonist Citation Mostafa MEA and Alrasheed T (2025) Improvement of irritable bowel syndrome with glucagon like peptide-1 receptor agonists: a systematic review and meta-analysis

Finally, due to the small number of events occurring across studies, the results for severe gastrointestinal AEs and discontinuation outcomes were particularly sensitive to small differences in events and allow for broad comparisons only

Nitric Oxide Booster TRAVEL SIZE

The Judicial Panel on Multidistrict Litigation (JPML) received a request to create a federal consolidated claim separate from the ongoing one for other side effects from GLP-1 drugs

Nausea, diarrhea, and constipation are the most common and often lessen with time

If this persists for several weeks in a row, especially on days that arent right before your next injection, its worth a conversation